Association of Disease-Modifying Therapies with COVID-19 Susceptibility and Severity in Patients with Multiple Sclerosis: A Systematic Review and Network Meta-Analysis

BACKGROUND: We conducted this study to assess the effect of disease-modifying therapies (DMTs) on coronavirus disease (COVID-19) susceptibility and severity in people with multiple sclerosis (MS). METHODS: Available studies from PubMed, Scopus, EMBASE, Web of Science, and gray literature, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzegar, Mahdi, Houshi, Shakiba, Sadeghi, Erfan, Hashemi, Mozhgan Sadat, Pishgahi, Ghasem, Bagherieh, Sara, Afshari-Safavi, Alireza, Mirmosayyeb, Omid, Shaygannejad, Vahid, Zabeti, Aram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519336/
https://www.ncbi.nlm.nih.gov/pubmed/36187599
http://dx.doi.org/10.1155/2022/9388813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519336/
https://www.ncbi.nlm.nih.gov/pubmed/36187599
http://dx.doi.org/10.1155/2022/9388813

Ejemplares similares